US20090324754A1 - Eucalyptus extract, method of preparation and therapeutic uses thereof - Google Patents

Eucalyptus extract, method of preparation and therapeutic uses thereof Download PDF

Info

Publication number
US20090324754A1
US20090324754A1 US12/309,754 US30975407A US2009324754A1 US 20090324754 A1 US20090324754 A1 US 20090324754A1 US 30975407 A US30975407 A US 30975407A US 2009324754 A1 US2009324754 A1 US 2009324754A1
Authority
US
United States
Prior art keywords
macrocarpal
eucalyptus
group
extract
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/309,754
Other languages
English (en)
Inventor
Christel Fiorini-Puybaret
Bernard Fabre
Cécile Chauvin
Philippe Joulia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Assigned to PIERRE FABRE MEDICAMENT reassignment PIERRE FABRE MEDICAMENT ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHAUVIN, CECILE, FABRE, BERNARD, FIORINI-PUYBARET, CHRISTEL, JOULIA, PHILIPPE
Publication of US20090324754A1 publication Critical patent/US20090324754A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
US12/309,754 2006-08-01 2007-07-27 Eucalyptus extract, method of preparation and therapeutic uses thereof Abandoned US20090324754A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0607201 2006-08-01
FR0607201A FR2904557B1 (fr) 2006-08-01 2006-08-01 Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques
PCT/FR2007/001309 WO2008017752A2 (fr) 2006-08-01 2007-07-27 Extrait d ' eucalyptus, son procede de preparation et ses utilisations therapeutiques

Publications (1)

Publication Number Publication Date
US20090324754A1 true US20090324754A1 (en) 2009-12-31

Family

ID=37708427

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/309,754 Abandoned US20090324754A1 (en) 2006-08-01 2007-07-27 Eucalyptus extract, method of preparation and therapeutic uses thereof

Country Status (20)

Country Link
US (1) US20090324754A1 (fr)
EP (1) EP2049133A2 (fr)
JP (1) JP2010500974A (fr)
KR (1) KR20090034401A (fr)
CN (1) CN101511378A (fr)
AR (1) AR062165A1 (fr)
AU (1) AU2007283529A1 (fr)
BR (1) BRPI0714863A2 (fr)
CA (1) CA2659162A1 (fr)
FR (1) FR2904557B1 (fr)
IL (1) IL196788A0 (fr)
MA (1) MA30592B1 (fr)
MX (1) MX2009000673A (fr)
NO (1) NO20090951L (fr)
NZ (1) NZ574429A (fr)
RU (1) RU2445112C2 (fr)
TN (1) TN2009000018A1 (fr)
TW (1) TW200820961A (fr)
UA (1) UA99598C2 (fr)
WO (1) WO2008017752A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110129554A1 (en) * 2008-06-17 2011-06-02 Lotte Co., Ltd. Method For Preparation Of Eucalyptus Extract
WO2013160881A1 (fr) * 2012-04-26 2013-10-31 Universidade De Aveiro Procédé d'obtention d'un extrait riche en acides triterpéniques à partir d'écorces d'eucalyptus

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926547B1 (fr) * 2008-01-18 2010-04-23 Pf Medicament 5-°1-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h- cyclopropa°a!naphtalen-4-yl)-3-methylbutyl!-2,4,6-trihydroxy -1,3-benzenedicarboxaldehyde en tant que medicaments.
GB2465228A (en) * 2008-11-15 2010-05-19 Athena Health Patents Inc Analogues of phloroglucinols from eucalyptus plant varieties and related compounds and their use in treating neurodegenerative disorders
CN102085169B (zh) * 2011-01-30 2012-08-29 广州中涵生物科技有限公司 一种使黑头溶解同步收细毛孔的制剂
KR102115037B1 (ko) * 2013-12-04 2020-05-25 코웨이 주식회사 상고머리 야테 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물
US20160317596A1 (en) * 2013-12-18 2016-11-03 Thylabisco Ab Use of Thylakoids to Reduce the Urge for Palatable Food
US10143706B2 (en) 2016-06-29 2018-12-04 Cannscience Innovations, Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
CN109172554A (zh) * 2018-09-06 2019-01-11 淮安安莱生物科技有限公司 大果桉醛c在制备治疗人肝癌的药物方面的应用
KR102212193B1 (ko) 2019-07-15 2021-02-03 박경호 인동등 및 유칼립투스 추출물을 유효성분으로 포함하는 인지기능장애 예방 또는 치료용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11137232A (ja) * 1997-08-02 1999-05-25 Ever Bright Ind Corp ハーブ製品
US20030031735A1 (en) * 2000-01-18 2003-02-13 Nagaoka Perfumery Co., Ltd Anti-obestic composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2329297A1 (fr) * 1975-10-29 1977-05-27 Rougier Yves Inhalateur buccal
JP3365782B2 (ja) * 1990-11-22 2003-01-14 株式会社ロッテ 新規マクロカルパール類及びその製造法
DE4447336C2 (de) * 1994-12-31 1996-12-19 Goebel Hartmut J Dr Med Habil Verwendung eines Gemisches aus Cineol und Menthol
JPH08198765A (ja) * 1995-01-31 1996-08-06 Hayami Kinugawa 鎮痛用医薬組成物
JP4809980B2 (ja) * 2000-01-18 2011-11-09 長岡香料株式会社 抗動脈硬化症剤
CA2470603A1 (fr) * 2001-12-19 2003-07-03 The Quigley Corporation Procedes de traitement de malaises neurovasculaires peripheriques
JP4979181B2 (ja) * 2003-01-31 2012-07-18 株式会社ヤクルト本社 グリケーション阻害剤及びその利用
JP2005272431A (ja) * 2004-03-24 2005-10-06 Yukio Kitagawa アロマセラピー品

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11137232A (ja) * 1997-08-02 1999-05-25 Ever Bright Ind Corp ハーブ製品
US20030031735A1 (en) * 2000-01-18 2003-02-13 Nagaoka Perfumery Co., Ltd Anti-obestic composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110129554A1 (en) * 2008-06-17 2011-06-02 Lotte Co., Ltd. Method For Preparation Of Eucalyptus Extract
US9402407B2 (en) * 2008-06-17 2016-08-02 Lotte Co., Ltd. Method for preparation of eucalyptus extract
WO2013160881A1 (fr) * 2012-04-26 2013-10-31 Universidade De Aveiro Procédé d'obtention d'un extrait riche en acides triterpéniques à partir d'écorces d'eucalyptus

Also Published As

Publication number Publication date
RU2445112C2 (ru) 2012-03-20
BRPI0714863A2 (pt) 2013-05-21
FR2904557A1 (fr) 2008-02-08
AR062165A1 (es) 2008-10-22
RU2009107166A (ru) 2010-09-10
NZ574429A (en) 2012-01-12
WO2008017752A3 (fr) 2008-04-10
KR20090034401A (ko) 2009-04-07
FR2904557B1 (fr) 2010-04-30
UA99598C2 (ru) 2012-09-10
EP2049133A2 (fr) 2009-04-22
NO20090951L (no) 2009-04-24
TN2009000018A1 (fr) 2010-08-19
WO2008017752A2 (fr) 2008-02-14
TW200820961A (en) 2008-05-16
CN101511378A (zh) 2009-08-19
MA30592B1 (fr) 2009-07-01
AU2007283529A1 (en) 2008-02-14
JP2010500974A (ja) 2010-01-14
IL196788A0 (en) 2009-11-18
CA2659162A1 (fr) 2008-02-14
MX2009000673A (es) 2009-02-04

Similar Documents

Publication Publication Date Title
US20090324754A1 (en) Eucalyptus extract, method of preparation and therapeutic uses thereof
US20180193399A1 (en) Compound and method for treating spasms, inflammation and pain
EP1326598A1 (fr) Procede pour produire un extrait contenant du tetrahydrocannabinol et du cannabidiol a partir de plantes de cannabis et extraits de cannabis
US20180271924A1 (en) Compound and method for reducing inflammation, pain, allergy, flu and cold symptoms
Kesharwani et al. A review on therapeutics application of eucalyptus oil
JPH06507601A (ja) セスキテルペンラクトンの抽出方法
US7780997B2 (en) Pharmaceutically active extracts of vitex leucoxylon, a process of extracting the same and a method of treating diabetes and inflammatory diseases therewith
Aggarwal et al. Ocimum tenuiflorum-a medicinal plants with its versatile uses
RU2213570C2 (ru) ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО ИЗ ЛИСТЬЕВ ЛИПЫ Folia Tilia И СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТИВНЫХ ВЕЩЕСТВ
US8642769B2 (en) Peperidine-flavan alkaloid compounds derived from African herb tea kinkeliba as anti-diabetic agents
Iqbal et al. Ma-Huang
JP2024504686A (ja) 尿路結石症関連疾患を治療するための薬物、およびその調製方法
RU2453527C2 (ru) 5-[1'-(ДЕКАГИДРО-7-ГИДРОКСИ-1,1,3a,7-ТЕТРАМЕТИЛ-1Н-ЦИКЛОПРОПА[A]НАФТАЛИН-4-ИЛ)-3'-МЕТИЛБУТИЛ]-2,4,6-ТРИГИДРОКСИ-1,3-БЕНЗОЛДИКАРБОКСАЛЬДЕГИД В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ
Htwe et al. Isolation of bioactive compounds from bark of Mimusops elengi Roxb.(Kha-yay) used in the treatment of hyperglycemia
KR0163813B1 (ko) 인동으로부터 유효활성 성분을 추출·정제하는 방법과 그 추출물을 함유한 생약조성물
Tohar Volatile compounds and alkaloids from the aqueous extract of Mitragyna speciosa and their in vitro and in vivo anti-inflammatory studies
Ricardo et al. Argemone ochroleuca: Biology, pharmacological potential and perspectives
FR2940614A1 (fr) Utilisation antibacterienne d'un extrait de morus australis poir et du compose kuwanone h
JP2009269896A (ja) 抗糖尿病食品または医薬品素材及び抗糖尿病食品または医薬品
Dafar et al. A Review on Phytochemical and Pharmacological Study of Herbal Medicinal Plant: Abrus precatorious
Kabasia A phytochemical study of selected medicinal herbs
Alam Cytotoxic and antioxidant activity in aqueous fraction of Opuntia elatior extract
JP2000128799A (ja) アルドースリダクターゼ阻害作用剤
US20110313034A1 (en) Neuroactive plant extract from hypericum polyanthemum
Suryadevara Chapter-1 Indian Medicinal Plants and Its Therapeutic Importance with Special Reference to Swietenia macrophylla: A Review

Legal Events

Date Code Title Description
AS Assignment

Owner name: PIERRE FABRE MEDICAMENT, FRANCE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FIORINI-PUYBARET, CHRISTEL;FABRE, BERNARD;CHAUVIN, CECILE;AND OTHERS;REEL/FRAME:023363/0510

Effective date: 20090108

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION